Waters reports 30% sales increase in Q1

By The Science Advisory Board staff writers

May 5, 2021 -- Lab equipment supplier Waters reported significant sales growth during the first quarter of 2021.

Sales grew 31% to $609 million during the first quarter of 2021 (end-April 3). Sales were $465 million during the first quarter of 2020. Adjusted free cash flow increased 60% to $193 million in the first quarter of 2021, compared to $121 million during the same period the year before, according to the company.

"There is much to be pleased about with our first quarter results, driven by strong growth across each of our major end markets, with pharma leading the way," said Udit Batra, PhD, president and CEO of Waters. "Thanks to solid execution and instrument sales growing in double-digits, we saw revenue increases across every region, with China's sales more than doubling."

Waters, Genovis team up on automated CQA characterization
Waters and Genovis are working together to develop and market routine biopharmaceutical characterization workflows of critical quality attributes (CQAs)...
Waters launches MAM workflow for protein-based drug analysis
Waters has introduced a new peptide multiattribute method (MAM) workflow for its BioAccord liquid chromatography-mass spectrometry system.
Waters launches new small molecule mass spectrometer
Waters has released its new time-of-flight mass spectrometer, the Acquity RDa Detector, for small molecule analysis.
Waters debuts new products at Pittcon 2020
Waters has introduced three new analytical products that support the development of next-generation, high-performance materials at Pittcon 2020 in Chicago....

Copyright © 2021 scienceboard.net

Cell Bio 2021
December 11-15
San Diego, California United States
Antibody Engineering and Therapeutics
December 13-17
San Diego, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter